Annual CFF
$841.00 K
+$841.00 K+100.00%
31 December 2023
Summary:
Eliem Therapeutics annual cash flow from financing activities is currently $841.00 thousand, with the most recent change of +$841.00 thousand (+100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$176.39 million (-99.53%).ELYM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$2.27 M
-$126.13 M-98.23%
30 September 2024
Summary:
Eliem Therapeutics quarterly cash flow from financing activities is currently $2.27 million, with the most recent change of -$126.13 million (-98.23%) on 30 September 2024. Over the past year, it has increased by +$1.98 million (+688.54%).ELYM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$130.98 M
+$1.74 M+1.35%
30 September 2024
Summary:
Eliem Therapeutics TTM cash flow from financing activities is currently $130.98 million, with the most recent change of +$1.74 million (+1.35%) on 30 September 2024. Over the past year, it has increased by +$130.13 million (+15473.84%).ELYM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELYM Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +688.5% | +10000.0% |
| 3 y3 years | -99.5% | +5876.3% | -26.1% |
| 5 y5 years | -96.8% | - | - |
ELYM Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -99.5% | -98.2% | -28.1% |
Eliem Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.27 M(-98.2%) | $130.98 M(+1.3%) |
| June 2024 | - | $128.40 M(>+9900.0%) | $129.23 M(>+9900.0%) |
| Mar 2024 | - | $15.00 K(-94.8%) | $855.00 K(+1.7%) |
| Dec 2023 | $841.00 K(>+9900.0%) | $288.00 K(-45.5%) | $841.00 K(+52.1%) |
| Sept 2023 | - | $528.00 K(+2100.0%) | $553.00 K(+2112.0%) |
| June 2023 | - | $24.00 K(+2300.0%) | $25.00 K(+2400.0%) |
| Mar 2023 | - | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) |
| Dec 2022 | $0.00 | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2022 | - | $0.00(0.0%) | $38.00 K(-100.0%) |
| June 2022 | - | $0.00(0.0%) | $83.18 M(-41.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $0.00(-100.0%) | $143.15 M(-19.2%) |
| Dec 2021 | $177.23 M(+3498.6%) | $38.00 K(-100.0%) | $177.23 M(-2.7%) |
| Sept 2021 | - | $83.14 M(+38.6%) | $182.12 M(+84.0%) |
| June 2021 | - | $59.97 M(+75.9%) | $98.97 M(+153.7%) |
| Mar 2021 | - | $34.08 M(+592.0%) | $39.01 M(+692.0%) |
| Dec 2020 | $4.92 M(-81.2%) | $4.92 M(>+9900.0%) | $4.92 M(>+9900.0%) |
| Sept 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $26.24 M | - | - |
FAQ
- What is Eliem Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Eliem Therapeutics?
- What is Eliem Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Eliem Therapeutics?
- What is Eliem Therapeutics quarterly CFF year-on-year change?
- What is Eliem Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Eliem Therapeutics?
- What is Eliem Therapeutics TTM CFF year-on-year change?
What is Eliem Therapeutics annual cash flow from financing activities?
The current annual CFF of ELYM is $841.00 K
What is the all time high annual CFF for Eliem Therapeutics?
Eliem Therapeutics all-time high annual cash flow from financing activities is $177.23 M
What is Eliem Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of ELYM is $2.27 M
What is the all time high quarterly CFF for Eliem Therapeutics?
Eliem Therapeutics all-time high quarterly cash flow from financing activities is $128.40 M
What is Eliem Therapeutics quarterly CFF year-on-year change?
Over the past year, ELYM quarterly cash flow from financing activities has changed by +$1.98 M (+688.54%)
What is Eliem Therapeutics TTM cash flow from financing activities?
The current TTM CFF of ELYM is $130.98 M
What is the all time high TTM CFF for Eliem Therapeutics?
Eliem Therapeutics all-time high TTM cash flow from financing activities is $182.12 M
What is Eliem Therapeutics TTM CFF year-on-year change?
Over the past year, ELYM TTM cash flow from financing activities has changed by +$130.13 M (+15473.84%)